06 Dec 2016
Highlights from the 2016 ACIPC Conference
06 Dec 2016
Melbourne Immunotherapy Network launches with inaugural symposium
01 Dec 2016
Doherty Institute welcomes new Director to WHO Collaborating Centre
Malaria in pregnancy
In a recent study in PNG, the Rogerson Group found that their drug combination decreased low birth weight babies by a quarter.
Environmental surveillance for poliovirus
The lab tests sewage collected at sentinel sites in Australia - even negative results for poliovirus are of international significance in the fight to eradicate polio.
Novel approaches to hepatitis B cure
Hepatitis B is currently incurable, the Revill Group is looking at novel therapeutic targets that may lead to a cure.
in 2017, the Doherty Institute will offer its inaugural PhD Program. Click here to learn more.
The Doherty Institute has a range of spaces available for hire that can cater for meetings, seminars and other larger events.
Breakthroughs happen when research leaders work with philanthropists to solve difficult and pressing global health problems.
Meet Dr Ann Bull. She is an epidemiologist and the Operations Director and VICNISS. Ann’s particular interests include improving the use of antibiotics given as prophylaxis for surgery and the development of interventions to reduce hospital acquired infections.
Meet Dr Thomas Schulz. He is an infectious diseases physician at the Victorian Infectious Diseases Service. He has a particular interest in refugee and immigrant health, and has a major interest in novel modes of health care delivery.